Within the "Takis Education" program, Dr Sibilio will provide the state of art for the development of biologics: from discovery in the lab to a real Biotech product.

This process requires expertise, technology transfer capabilities and deep knowledge of the regulatory path. Therefore, finding the appropriate partner since the arly phase is key to success.

Join us to learn how complex is the development of a recombinant protein or an antibody and what are potential shortcuts.